A pharmaceutical composition for treating cancer comprising trypsinogen and/ or chymotrypsinogen and an active agent selected from a selenium compound, a vanilloid compound and a cytoplasmic glycolysis reduction agent

Details for Australian Patent Application No. 2010310887 (hide)

Owner Propanc Pty Ltd

Inventors Kenyon, Julian Norman; Clayton, Paul Rodney; Tosh, David; Felquer, Fernando; Brandt, Ralf

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2010310887

PCT Pub. Number WO2011/047434

Priority 2009905147 22.10.09 AU; 2010902655 17.06.10 AU

Filing date 22 October 2010

Wipo publication date 28 April 2011

International Classifications

A61K 38/47 (2006.01) Medicinal preparations containing peptides

A61K 31/095 (2006.01) - Sulfur, selenium or tellurium compounds, e.g. thiols

A61K 31/21 (2006.01) - Esters, e.g. nitroglycerine, selenocyanates

A61K 38/48 (2006.01) Medicinal preparations containing peptides

A61K 38/54 (2006.01) Medicinal preparations containing peptides

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

7 June 2012 PCT application entered the National Phase

  PCT publication WO2011/047434 Priority application(s): WO2011/047434

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010310889-Methods and apparatus for growing plants

2010310882-Acoustic panel